IASO PHARMA INC — Form D
IASO PHARMA INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-22. The offering totals $5.5M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-02-22
- Form: D
- Accession: 0000921895-10-000234
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.5M
- Amount sold: $2.6M
- Remaining: $2.9M
- Minimum investment: $20K
- Investors: 29
- Date of first sale: 2010-02-09
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-112672
Issuer
- Name: IASO PHARMA INC
- CIK: 0001422702
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 12707 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Phone: 858-350-4312
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jay J Lobell | Director | Miami, FL |
| James Rock | Executive Officer | Pittsburgh, PA |
| Jonah J Lobell | Director | San Diego, CA |
| Jai Jun (Matthew) W Choung | Director | San Diego, CA |
| Gary G Gemignani | Director | San Diego, CA |
| James W Rock | Executive Officer | San Diego, CA |
| Michael G Rice | Director | San Diego, CA |
| James W Klingler | Executive Officer | San Diego, CA |
| Michael L Corrado | Director | Perkasie, PA |
| Matthew A Wikler | Director | La Jolla, CA |
| Matthew A Wikler | Executive Officer | La Jolla, CA |
| Mark W Lotz | Executive Officer | La Jolla, CA |
Other filings by this issuer (2)
More